<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Liver Dis (Hoboken)</journal-id><journal-id journal-id-type="iso-abbrev">Clin Liver Dis (Hoboken)</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2046-2484</journal-id><journal-id journal-id-type="publisher-id">CLD</journal-id><journal-title-group><journal-title>Clinical Liver Disease</journal-title></journal-title-group><issn pub-type="epub">2046-2484</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7242012</article-id><article-id pub-id-type="doi">10.1002/cld.973</article-id><article-id pub-id-type="publisher-id">CLD973</article-id><article-categories><subj-group subj-group-type="overline"><subject>Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Reviews</subject></subj-group></article-categories><title-group><article-title>The COVID&#x02010;19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief</article-title><alt-title alt-title-type="right-running-head">The COVID&#x02010;19 Pandemic</alt-title><alt-title alt-title-type="left-running-head">Ward and Del Rio</alt-title></title-group><contrib-group><contrib id="cld973-cr-0001" contrib-type="author" corresp="yes"><name><surname>Ward</surname><given-names>John W.</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="cld973-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="cld973-aff-0002">
<sup>2</sup>
</xref><address><email>jward@taskforce.org</email></address></contrib><contrib id="cld973-cr-0002" contrib-type="author"><name><surname>del Rio</surname><given-names>Carlos</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="cld973-aff-0002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="cld973-aff-0003">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="cld973-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Coalition for Global Hepatitis Elimination</named-content>
<institution>Task Force for Global Health</institution>
<city>Decatur</city>
<named-content content-type="country-part">GA</named-content>
</aff><aff id="cld973-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Hubert Department of Global Health</named-content>
<named-content content-type="organisation-division">Rollins School of Public Health</named-content>
<institution>Emory University</institution>
<city>Atlanta</city>
<named-content content-type="country-part">GA</named-content>
</aff><aff id="cld973-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Medicine</named-content>
<institution>Emory University School of Medicine</institution>
<city>Atlanta</city>
<named-content content-type="country-part">GA</named-content>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label>
Correspondence<break/>
John W. Ward, M.D., Director, Coalition for Global Hepatitis Elimination, The Task Force for Global Health, 330 W. Ponce de Leon Ave., Decatur, GA 30030. E&#x02010;mail: <email>jward@taskforce.org</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>5</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2020</year></pub-date><volume>15</volume><issue>5</issue><issue-id pub-id-type="doi">10.1002/cld.v15.5</issue-id><issue-title content-type="special-issue-title">COVID&#x02010;19 and Liver Disease</issue-title><fpage>170</fpage><lpage>174</lpage><history><date date-type="received"><day>03</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>08</day><month>5</month><year>2020</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 by the American Association for the Study of Liver Diseases <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2020 by the American Association for the Study of Liver Diseases</copyright-statement></permissions><self-uri content-type="pdf" xlink:href="file:CLD-15-170.pdf"/><counts><fig-count count="1"/><table-count count="3"/><page-count count="5"/><word-count count="5468"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2020</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.2 mode:remove_FC converted:21.05.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="cld973-ntgp-0001"><fn id="cld973-note-0001"><p>Potential conflict of interest: Nothing to report.</p></fn></fn-group></notes></front><body id="cld973-body-0001"><boxed-text position="anchor" orientation="portrait"><p content-type="mediaLink">
<ext-link ext-link-type="uri" xlink:href="http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/15-5-interview-ward-delrio">http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/15-5-interview-ward-delrio</ext-link> the interview with the author</p></boxed-text><def-list list-content="abbreviations" id="cld973-lp-0001"><title>Abbreviations</title><def-item><term>ACE2</term><def><p>angiotensin&#x02010;converting enzyme 2</p></def></def-item><def-item><term>CDC</term><def><p>Centers for Disease Control and Prevention</p></def></def-item><def-item><term>COVID&#x02010;19</term><def><p>coronavirus disease 2019</p></def></def-item><def-item><term>CT</term><def><p>computed tomography</p></def></def-item><def-item><term>FDA</term><def><p>US Food and Drug Administration</p></def></def-item><def-item><term>IL&#x02010;6</term><def><p>interleukin&#x02010;6</p></def></def-item><def-item><term>RT&#x02010;PCR</term><def><p>reverse transcription polymerase chain reaction</p></def></def-item><def-item><term>SARS</term><def><p>severe acute respiratory syndrome</p></def></def-item><def-item><term>WHO</term><def><p>World Health Organization</p></def></def-item></def-list><p>On December 29, 2019, health authorities in China reported 27 cases of an unusual pneumonia, respiratory failure, and death linked to attendance at a live animal market in Wuhan.<xref rid="cld973-bib-0001" ref-type="ref">
<sup>1</sup>
</xref>, <xref rid="cld973-bib-0002" ref-type="ref">
<sup>2</sup>
</xref> On January 7, 2020, Chinese scientists confirmed a novel coronavirus, 2019&#x02010;nCoV, as the causative agent.<xref rid="cld973-bib-0003" ref-type="ref">
<sup>3</sup>
</xref> Studies revealed &#x0003e;80% genetic homology of 2019&#x02010;nCoV with coronaviruses of bats, presumably the original host; pangolins, suggesting this animal sold at the market as an intermediate host; and another human coronavirus, SARS&#x02010;CoV, the cause of severe acute respiratory syndrome (SARS).<xref rid="cld973-bib-0003" ref-type="ref">
<sup>3</sup>
</xref>, <xref rid="cld973-bib-0004" ref-type="ref">
<sup>4</sup>
</xref> All evidence indicates that SARS&#x02010;CoV&#x02010;2 is of animal and not laboratory origin.<xref rid="cld973-bib-0005" ref-type="ref">
<sup>5</sup>
</xref> The World Health Organization (WHO) later named the novel virus SARS&#x02010;CoV&#x02010;2 and the related disease coronavirus disease 2019 (COVID&#x02010;19).<xref rid="cld973-bib-0002" ref-type="ref">
<sup>2</sup>
</xref>, <xref rid="cld973-bib-0003" ref-type="ref">
<sup>3</sup>
</xref> SARS&#x02010;CoV&#x02010;2 spread quickly through communities in China and other countries (Fig. <xref rid="cld973-fig-0001" ref-type="fig">1</xref>). On January 20, 2020, the first case was recognized in the United State when a 35&#x02010;year&#x02010;old man presented to an urgent care clinic in Snohomish, Washington.<xref rid="cld973-bib-0006" ref-type="ref">
<sup>6</sup>
</xref>, <xref rid="cld973-bib-0007" ref-type="ref">
<sup>7</sup>
</xref> On January 30, 2020, WHO declared the outbreak a Public Health Emergency of International Concern. On March 11, 2020, WHO designated COVID&#x02010;19 a pandemic. Almost all countries are implementing public health measures to prevent SARS&#x02010;CoV&#x02010;2 transmission and are marshaling clinical care for patients with COVID&#x02010;19. This review highlights key features of SARS&#x02010;CoV&#x02010;2 infection, the epidemiology and clinical course of COVID&#x02010;19, and interventions to stop the growing COVID&#x02010;19 pandemic.</p><fig fig-type="Fig" xml:lang="en" id="cld973-fig-0001" orientation="portrait" position="float"><label>Fig 1</label><caption><p>Chronology of the COVID&#x02010;19 pandemic.</p></caption><graphic id="nlm-graphic-1" xlink:href="CLD-15-170-g001"/></fig><sec id="cld973-sec-0002"><title>Epidemiology</title><p>By March 11, 2020, 105 countries had reported 118,319 confirmed COVID&#x02010;19 cases and 4292 deaths.<xref rid="cld973-bib-0002" ref-type="ref">
<sup>2</sup>
</xref> Outside China, large epidemics emerged in South Korea, Iran, and Italy. By March 14, 2020, approximately one in four COVID&#x02010;19 cases and deaths were in Europe. The US epidemic accelerated, with cases doubling every 6 to 7&#x000a0;days.<xref rid="cld973-bib-0007" ref-type="ref">
<sup>7</sup>
</xref> By March 29, 2020, more than 100,000 persons had COVID&#x02010;19 in the United States, the largest burden of COVID&#x02010;19 globally.<xref rid="cld973-bib-0002" ref-type="ref">
<sup>2</sup>
</xref>, <xref rid="cld973-bib-0007" ref-type="ref">
<sup>7</sup>
</xref> As of April 29, 2020, the COVID&#x02010;19 pandemic has grown to more than 3&#x000a0;million confirmed cases and more than 206,000 deaths in 179 countries. The United States now has more than 1&#x000a0;million cases (33%) and more than 50,000 deaths (25%).<xref rid="cld973-bib-0002" ref-type="ref">
<sup>2</sup>
</xref>, <xref rid="cld973-bib-0007" ref-type="ref">
<sup>7</sup>
</xref> The potential is high for large COVID&#x02010;19 epidemics in Brazil, Russia, India, and many African countries.</p><p>SARS&#x02010;CoV&#x02010;2 is transmitted directly through inhalation or mucosal surface exposure to an infected person&#x02019;s respiratory droplets or indirectly when touching the face after contact with contaminated objects.<xref rid="cld973-bib-0002" ref-type="ref">
<sup>2</sup>
</xref>, <xref rid="cld973-bib-0004" ref-type="ref">
<sup>4</sup>
</xref>, <xref rid="cld973-bib-0007" ref-type="ref">
<sup>7</sup>
</xref> SARS&#x02010;CoV&#x02010;2 can remain viable on environmental surfaces for up to 72&#x000a0;hours.<xref rid="cld973-bib-0008" ref-type="ref">
<sup>8</sup>
</xref> SARS&#x02010;CoV&#x02010;2 is highly infectious with an R0 of approximately 2.2 to 3.0, meaning each infected person will infect about two to three other persons.<xref rid="cld973-bib-0007" ref-type="ref">
<sup>7</sup>
</xref> Large COVID&#x02010;19 outbreaks have occurred in health care facilities, households, cruise ships, religious services (e.g., funerals), and other large gatherings<xref rid="cld973-bib-0001" ref-type="ref">
<sup>1</sup>
</xref>, <xref rid="cld973-bib-0002" ref-type="ref">
<sup>2</sup>
</xref>, <xref rid="cld973-bib-0007" ref-type="ref">
<sup>7</sup>
</xref> Individuals can transmit SARS&#x02010;CoV&#x02010;2 before, during, and after symptomatic disease. As many as half of individuals with SARS&#x02010;CoV&#x02010;2 infection have no symptoms.<xref rid="cld973-bib-0007" ref-type="ref">
<sup>7</sup>
</xref>
</p></sec><sec id="cld973-sec-0003"><title>Clinical Presentation</title><p>Similar to SARS&#x02010;CoV, SARS&#x02010;CoV&#x02010;2 binds to angiotensin&#x02010;converting enzyme 2 (ACE2) receptors for entry via endocytosis into alveolar epithelial cells, as well as other cells with ACE2 receptors in the heart, gastrointestinal tract, and kidneys.<xref rid="cld973-bib-0002" ref-type="ref">
<sup>2</sup>
</xref>, <xref rid="cld973-bib-0004" ref-type="ref">
<sup>4</sup>
</xref> COVID&#x02010;19 results from SARS&#x02010;CoV&#x02010;2 replication, causing early cell death (i.e., apoptosis) and provoking a storm of proinflammatory cytokines (e.g., interleukin&#x02010;6 [IL&#x02010;6]) disrupting alveolar walls with resulting fluid accumulation in alveoli.<xref rid="cld973-bib-0004" ref-type="ref">
<sup>4</sup>
</xref>
</p><p>The incubation period from infection to onset of COVID&#x02010;19 disease is typically 5 to 7&#x000a0;days (range 1&#x02010;14&#x000a0;days).<xref rid="cld973-bib-0001" ref-type="ref">
<sup>1</sup>
</xref>, <xref rid="cld973-bib-0002" ref-type="ref">
<sup>2</sup>
</xref>, <xref rid="cld973-bib-0007" ref-type="ref">
<sup>7</sup>
</xref> The most common symptoms of COVID&#x02010;19 are fever and nonproductive cough (Table <xref rid="cld973-tbl-0001" ref-type="table">1</xref>).<xref rid="cld973-bib-0001" ref-type="ref">
<sup>1</sup>
</xref>, <xref rid="cld973-bib-0004" ref-type="ref">
<sup>4</sup>
</xref>, <xref rid="cld973-bib-0007" ref-type="ref">
<sup>7</sup>
</xref>, <xref rid="cld973-bib-0009" ref-type="ref">
<sup>9</sup>
</xref> The Centers for Disease Control and Prevention (CDC) recently added anosmia and ageusia, the loss of smell and taste, as COVID&#x02010;19 symptoms.<xref rid="cld973-bib-0007" ref-type="ref">
<sup>7</sup>
</xref> Laboratory findings are remarkable for a normal leukocyte count, lymphopenia, and elevated C&#x02010;reactive protein.<xref rid="cld973-bib-0001" ref-type="ref">
<sup>1</sup>
</xref>, <xref rid="cld973-bib-0006" ref-type="ref">
<sup>6</sup>
</xref>, <xref rid="cld973-bib-0008" ref-type="ref">
<sup>8</sup>
</xref> Most hospitalized patients with COVID&#x02010;19 have a bilateral ground&#x02010;glass appearance on chest computed tomography (CT) scan consistent with viral pneumonia.</p><table-wrap id="cld973-tbl-0001" xml:lang="en" content-type="Table" orientation="portrait" position="float"><label>Table 1</label><caption><p>Clinical Features of COVID&#x02010;19 in Wuhan and Multiple Other Locations in China</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Clinical Features</th><th align="center" valign="top" rowspan="1" colspan="1">Wuhan, China</th><th align="center" valign="top" rowspan="1" colspan="1">Multiple Locations, China</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Number of patients</td><td align="center" rowspan="1" colspan="1">10,999</td><td align="center" rowspan="1" colspan="1">3,062</td></tr><tr><td align="left" rowspan="1" colspan="1">Symptoms</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Fever</td><td align="center" rowspan="1" colspan="1">89%</td><td align="center" rowspan="1" colspan="1">80%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Cough</td><td align="center" rowspan="1" colspan="1">68%</td><td align="center" rowspan="1" colspan="1">63%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Expectoration</td><td align="center" rowspan="1" colspan="1">34%</td><td align="center" rowspan="1" colspan="1">42%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Dyspnea</td><td align="center" rowspan="1" colspan="1">19%</td><td align="center" rowspan="1" colspan="1">34%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Fatigue/Myalgia</td><td align="center" rowspan="1" colspan="1">38%</td><td align="center" rowspan="1" colspan="1">46%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Headache</td><td align="center" rowspan="1" colspan="1">14%</td><td align="center" rowspan="1" colspan="1">15%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Nausea/Vomiting</td><td align="center" rowspan="1" colspan="1">5%</td><td align="center" rowspan="1" colspan="1">10%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Diarrhea</td><td align="center" rowspan="1" colspan="1">4%</td><td align="center" rowspan="1" colspan="1">13%</td></tr><tr><td align="left" rowspan="1" colspan="1">Laboratory results</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Leukocytes in normal range</td><td align="center" rowspan="1" colspan="1">94%</td><td align="center" rowspan="1" colspan="1">70%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Lymphopenia</td><td align="center" rowspan="1" colspan="1">83%</td><td align="center" rowspan="1" colspan="1">57%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Increased C&#x02010;reactive protein</td><td align="center" rowspan="1" colspan="1">61%</td><td align="center" rowspan="1" colspan="1">74%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Alanine aminotransferase above upper limit of normal</td><td align="center" rowspan="1" colspan="1">21%</td><td align="center" rowspan="1" colspan="1">29%</td></tr><tr><td align="left" rowspan="1" colspan="1">Imaging</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Abnormal chest CT</td><td align="center" rowspan="1" colspan="1">86%</td><td align="center" rowspan="1" colspan="1">89%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Bilateral infiltrates (ground glass)</td><td align="center" rowspan="1" colspan="1">56%</td><td align="center" rowspan="1" colspan="1">76%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Acute respiratory distress syndrome</td><td align="center" rowspan="1" colspan="1">6%</td><td align="center" rowspan="1" colspan="1">20%</td></tr><tr><td align="left" rowspan="1" colspan="1">Mortality</td><td align="center" rowspan="1" colspan="1">1.4%</td><td align="center" rowspan="1" colspan="1">6%</td></tr></tbody></table><table-wrap-foot id="cld973-ntgp-0002"><fn id="cld973-note-0002"><p>Data are from Guna et al.<xref rid="cld973-bib-0001" ref-type="ref">
<sup>1</sup>
</xref> and Centers for Disease Control and Prevention.<xref rid="cld973-bib-0007" ref-type="ref">
<sup>7</sup>
</xref>
</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>Today, reverse transcription polymerase chain reaction (RT&#x02010;PCR) is the COVID&#x02010;19 diagnostic test.<xref rid="cld973-bib-0002" ref-type="ref">
<sup>2</sup>
</xref>, <xref rid="cld973-bib-0007" ref-type="ref">
<sup>7</sup>
</xref> RT&#x02010;PCR sensitivity is highest for testing bronchial alveolar lavage fluid (93%) and declines for sputum (72%) and nasal swab (63%) specimens.<xref rid="cld973-bib-0010" ref-type="ref">
<sup>10</sup>
</xref> COVID&#x02010;19 diagnosis might require repeat testing.<xref rid="cld973-bib-0002" ref-type="ref">
<sup>2</sup>
</xref>, <xref rid="cld973-bib-0007" ref-type="ref">
<sup>7</sup>
</xref> Serological tests to detect SARS&#x02010;CoV&#x02010;2 IgM and IgG antibodies are available. However, because of test sensitivity and other quality concerns, the US Food and Drug Administration (FDA; <ext-link ext-link-type="uri" xlink:href="http://www.fda.gov">http://www.fda.gov</ext-link>) advises current serological tests are best used for surveillance and research, and not as the sole basis for COVID&#x02010;19 diagnosis.</p><p>COVID&#x02010;19 is commonly a mild disease. Of the first 72,314 COVID&#x02010;19 disease reported in China, 81% had no or mild pneumonia, 21% had severe dyspnea and radiological evidence of pulmonary disease, and 5% progressed to SARS.<xref rid="cld973-bib-0001" ref-type="ref">
<sup>1</sup>
</xref> Individuals can be ill for a week or longer before experiencing severe symptoms.</p><p>The risk for severe COVID&#x02010;19 disease is highest for men, older adults, and patients with certain comorbidities. In the United States, 80% of reported COVID&#x02010;19&#x02013;related deaths are among people aged &#x02265;65&#x000a0;years.<xref rid="cld973-bib-0007" ref-type="ref">
<sup>7</sup>
</xref>, <xref rid="cld973-bib-0009" ref-type="ref">
<sup>9</sup>
</xref>, <xref rid="cld973-bib-0011" ref-type="ref">
<sup>11</sup>
</xref> Deaths are rare among persons &#x0003c;24&#x000a0;years of age.<xref rid="cld973-bib-0001" ref-type="ref">
<sup>1</sup>
</xref>, <xref rid="cld973-bib-0007" ref-type="ref">
<sup>7</sup>
</xref>, <xref rid="cld973-bib-0011" ref-type="ref">
<sup>11</sup>
</xref> In the United States, most hospitalized patients with COVID&#x02010;19 have comorbid conditions, including obesity, hypertension, diabetes, and cardiovascular disease<xref rid="cld973-bib-0007" ref-type="ref">
<sup>7</sup>
</xref>, <xref rid="cld973-bib-0011" ref-type="ref">
<sup>11</sup>
</xref> (Table <xref rid="cld973-tbl-0002" ref-type="table">2</xref>). Although listed by the CDC as a comorbid condition associated with severe COVID&#x02010;19, chronic liver disease, including cirrhosis, has not been a common comorbidity associated with hospitalization in the United States (Table <xref rid="cld973-tbl-0002" ref-type="table">2</xref>). The high prevalence of comorbid conditions can explain, in part, African Americans&#x02019; increased risk for hospitalization with COVID&#x02010;19 disease.<xref rid="cld973-bib-0005" ref-type="ref">
<sup>5</sup>
</xref> Variable comorbidity prevalence contributes to differences in national COVID mortality. Globally, crude fatality rates for COVID&#x02010;19 range from 0.2% in Singapore, to 2.0% to 3.0% in South Korea and Germany, to 4.3% for the United States, and to 10% to 13% in Spain, Italy, and the United Kingdom.<xref rid="cld973-bib-0002" ref-type="ref">
<sup>2</sup>
</xref>, <xref rid="cld973-bib-0005" ref-type="ref">
<sup>5</sup>
</xref>
</p><table-wrap id="cld973-tbl-0002" xml:lang="en" content-type="Table" orientation="portrait" position="float"><label>Table 2</label><caption><p>Comorbidities Among Persons With COVID&#x02010;19 Disease, United States</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="bottom" colspan="1">Condition</th><th align="center" colspan="3" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">United States<xref ref-type="fn" rid="cld973-note-0003">*</xref>
</th><th align="center" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">New York City</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" valign="bottom" rowspan="1" colspan="1">Not Hospitalized</th><th align="center" valign="bottom" rowspan="1" colspan="1">Hospitalized</th><th align="center" valign="bottom" rowspan="1" colspan="1">Intensive Care</th><th align="center" valign="bottom" rowspan="1" colspan="1">Hospitalized</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Patients</td><td align="center" rowspan="1" colspan="1">5143</td><td align="center" rowspan="1" colspan="1">1037</td><td align="center" rowspan="1" colspan="1">457</td><td align="center" rowspan="1" colspan="1">5700</td></tr><tr><td align="left" rowspan="1" colspan="1">One or more condition</td><td align="center" rowspan="1" colspan="1">27%</td><td align="center" rowspan="1" colspan="1">71%</td><td align="center" rowspan="1" colspan="1">78%</td><td align="center" rowspan="1" colspan="1">88%</td></tr><tr><td align="left" rowspan="1" colspan="1">Obesity</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">42%</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">57%</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes mellitus</td><td align="center" rowspan="1" colspan="1">6%</td><td align="center" rowspan="1" colspan="1">24%</td><td align="center" rowspan="1" colspan="1">32%</td><td align="center" rowspan="1" colspan="1">34%</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardiovascular disease</td><td align="center" rowspan="1" colspan="1">5%</td><td align="center" rowspan="1" colspan="1">23%</td><td align="center" rowspan="1" colspan="1">29%</td><td align="center" rowspan="1" colspan="1">18%</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic renal disease</td><td align="center" rowspan="1" colspan="1">1%</td><td align="center" rowspan="1" colspan="1">9%</td><td align="center" rowspan="1" colspan="1">12%</td><td align="center" rowspan="1" colspan="1">0.6%</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic liver disease</td><td align="center" rowspan="1" colspan="1">1%</td><td align="center" rowspan="1" colspan="1">1%</td><td align="center" rowspan="1" colspan="1">2%</td><td align="center" rowspan="1" colspan="1">9%</td></tr><tr><td align="left" rowspan="1" colspan="1">Immunocompromised</td><td align="center" rowspan="1" colspan="1">3%</td><td align="center" rowspan="1" colspan="1">6%</td><td align="center" rowspan="1" colspan="1">9%</td><td align="center" rowspan="1" colspan="1">2%</td></tr><tr><td align="left" rowspan="1" colspan="1">Mortality</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">21%</td></tr><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">21%</td></tr><tr><td align="left" rowspan="1" colspan="1">1 Comorbidity</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">88%</td></tr></tbody></table><table-wrap-foot id="cld973-ntgp-0003"><fn id="cld973-note-0003"><label>*</label><p>Based on data from the CDC for all 50 states and territories. Otherwise, data are Richardson et al.<xref rid="cld973-bib-0011" ref-type="ref">
<sup>11</sup>
</xref>
</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>The search for effective therapies and a vaccine is occurring at a remarkable pace, with at least 29 studies of therapeutic agents and 5 studies of candidate vaccines registered on ClinicalTrials.org (<ext-link ext-link-type="uri" xlink:href="https://www.clinicaltrials.gov">https://www.clinicaltrials.gov</ext-link>). On May 1, 2020, the FDA granted Emergency Use Authorization of remdesivir, a broad&#x02010;spectrum antiviral nucleotide prodrug for treatment of severe COVID&#x02010;19. Studies of monoclonal antibodies against IL&#x02010;6 and hyperimmune immunoglobulin are in progress. Following reports of serious cardiac arrythmias, the FDA cautioned clinicians of prescribing hydroxychloroquine or chloroquine for treatment of COVID&#x02010;19. A safe and effective vaccine, if successfully developed, probably will not be available for 12 to 18&#x000a0;months.</p></sec><sec id="cld973-sec-0004"><title>Prevention</title><p>In the absence of a vaccine, prevention is composed of a combination of nonpharmacological interventions for suppression of transmission to R0 &#x0003c;1 and mitigation of the number of patients with COVID&#x02010;19 who require intensive care and mechanical respiratory support.<xref rid="cld973-bib-0012" ref-type="ref">
<sup>12</sup>
</xref> Interventions include improved personal hygiene promotions, symptomatic screening and laboratory testing for case detection, contact tracing, household quarantine of those with transmission risks, and social distancing (Table <xref rid="cld973-tbl-0003" ref-type="table">3</xref>). The United States and most other countries have implemented extensive travel restrictions, workplace and school closures, and cancellation of sporting and other large public events. China, South Korea, and Taiwan successfully curbed large COVID&#x02010;19 epidemics with prompt scale&#x02010;up of testing, contact tracing, and quarantine.<xref rid="cld973-bib-0002" ref-type="ref">
<sup>2</sup>
</xref>, <xref rid="cld973-bib-0004" ref-type="ref">
<sup>4</sup>
</xref>, <xref rid="cld973-bib-0007" ref-type="ref">
<sup>7</sup>
</xref> In the United States, although testing rates are low, models suggest prevention measures are reducing transmission and future deaths.<xref rid="cld973-bib-0013" ref-type="ref">
<sup>13</sup>
</xref> The US government recently recommended increased COVID&#x02010;19 surveillance, testing, and contact tracing with modified social distancing measures to sustain SARS&#x02010;CoV&#x02010;2 prevention while opening up education and commerce.<xref rid="cld973-bib-0014" ref-type="ref">
<sup>14</sup>
</xref>
</p><table-wrap id="cld973-tbl-0003" xml:lang="en" content-type="Table" orientation="portrait" position="float"><label>Table 3</label><caption><p>Prevention Measures to Reduce Risks for COVID&#x02010;19, Priority Populations for Testing, and Information Resources</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><tbody><tr><td align="left" rowspan="3" colspan="1">Prevention measures to reduce risks for COVID&#x02010;19</td><td align="left" rowspan="1" colspan="1">
<p>
<list list-type="bullet" id="cld973-list-0001"><list-item><p>Practice good hygiene
</p><list list-type="simple" id="cld973-list-0002"><list-item><label>&#x025cb;</label><p>Wash hands often for &#x0003e;20&#x000a0;seconds with soap and water or 60% alcohol sanitizer</p></list-item><list-item><label>&#x025cb;</label><p>Avoid touching eyes, nose, and mouth with unwashed hands</p></list-item><list-item><label>&#x025cb;</label><p>Sneeze or cough into a tissue or inside of the elbow</p></list-item><list-item><label>&#x025cb;</label><p>Disinfect surfaces and used items frequently with soap and water and Environmental Protection Agency&#x02013;registered household disinfectants or bleach solution (4 teaspoons [20&#x000a0;mL] bleach per quart [or 1&#x000a0;L] water)</p></list-item></list></list-item></list>
</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<p>
<list list-type="bullet" id="cld973-list-0003"><list-item><p>Limit close social contact
</p><list list-type="simple" id="cld973-list-0004"><list-item><label>&#x025cb;</label><p>Learn signs and symptoms of COVID&#x02010;19, and follow local disease trends</p></list-item><list-item><label>&#x025cb;</label><p>Stay home as much as possible, particularly persons who are ill, older (&#x0003e;65&#x000a0;years) adults, and those at risk for severe COVID&#x02010;19</p></list-item><list-item><label>&#x025cb;</label><p>Persons who are ill, call a health care provider</p></list-item><list-item><label>&#x025cb;</label><p>Consider 2&#x02010;week supply of medications, food, and other essentials</p></list-item><list-item><label>&#x025cb;</label><p>When out in public, keep social distance of at least 6 feet and wear a cloth face cover</p></list-item><list-item><label>&#x025cb;</label><p>Avoid gatherings of &#x0003e;10 persons</p></list-item><list-item><label>&#x025cb;</label><p>Work or attend school from home</p></list-item><list-item><label>&#x025cb;</label><p>Avoid unnecessary travel</p></list-item><list-item><label>&#x025cb;</label><p>Avoid visits to nursing homes or long&#x02010;term retirement facilities</p></list-item></list></list-item></list>
</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<p>
<list list-type="bullet" id="cld973-list-0005"><list-item><p>Protect patients and health care workers
</p><list list-type="simple" id="cld973-list-0006"><list-item><label>&#x025cb;</label><p>Reduce facility risks: screen for COVID&#x02010;19 symptoms on entry; reduce visits; practice telemedicine</p></list-item><list-item><label>&#x025cb;</label><p>Isolate symptomatic patients as soon as possible</p></list-item><list-item><label>&#x025cb;</label><p>Protect health care personnel with recommended infection&#x02010;control procedures</p></list-item></list></list-item></list>
</p>
</td></tr><tr><td align="left" rowspan="3" colspan="1">Recommended testing in consultation with health care provider</td><td align="left" rowspan="1" colspan="1">
<p>
<list list-type="bullet" id="cld973-list-0007"><list-item><p>Hospitalized patients</p></list-item></list>
</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<p>
<list list-type="bullet" id="cld973-list-0008"><list-item><p>Persons with symptoms of COVID&#x02010;19
</p><list list-type="simple" id="cld973-list-0009"><list-item><label>&#x025cb;</label><p>Health care facility workers</p></list-item><list-item><label>&#x025cb;</label><p>Patients in long&#x02010;term care facilities</p></list-item><list-item><label>&#x025cb;</label><p>Patients &#x0003e;65&#x000a0;years of age</p></list-item><list-item><label>&#x025cb;</label><p>Patients with underlying conditions with symptoms</p></list-item><list-item><label>&#x025cb;</label><p>First responders</p></list-item></list></list-item></list>
</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<p>
<list list-type="bullet" id="cld973-list-0010"><list-item><p>Critical infrastructure workers and others with symptoms</p></list-item><list-item><p>Health care facility workers and first responders</p></list-item><list-item><p>Persons mildly ill in communities with high numbers of COVID&#x02010;19 hospitalizations</p></list-item></list>
</p>
</td></tr><tr><td align="left" rowspan="7" colspan="1">Good information resources</td><td align="left" rowspan="1" colspan="1">Centers for Disease Control and Prevention: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/index.html">https://www.cdc.gov/coronavirus/2019-ncov/index.html</ext-link>
</td></tr><tr><td align="left" rowspan="1" colspan="1">World Health Organization: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019">https://www.who.int/emergencies/diseases/novel-coronavirus-2019</ext-link>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Infectious Disease Society of America: <ext-link ext-link-type="uri" xlink:href="https://www.idsociety.org/public-health/COVID-19-Resource-Center/">https://www.idsociety.org/public-health/COVID-19-Resource-Center/</ext-link>
</td></tr><tr><td align="left" rowspan="1" colspan="1">American Association for the Study of Liver Diseases: <ext-link ext-link-type="uri" xlink:href="https://www.aasld.org/about-aasld/covid-19-resources">https://www.aasld.org/about-aasld/covid-19-resources</ext-link>
</td></tr><tr><td align="left" rowspan="1" colspan="1">European Association for the Study of the Liver: <ext-link ext-link-type="uri" xlink:href="https://easl.eu/covid-19-and-the-liver/">https://easl.eu/covid-19-and-the-liver/</ext-link>
</td></tr><tr><td align="left" rowspan="1" colspan="1">European Centre for Disease Control and Prevention: <ext-link ext-link-type="uri" xlink:href="https://www.ecdc.europa.eu/en/covid-19-pandemic">https://www.ecdc.europa.eu/en/covid-19-pandemic</ext-link>
</td></tr><tr><td align="left" rowspan="1" colspan="1">The Society for Healthcare Epidemiology of America: <ext-link ext-link-type="uri" xlink:href="https://www.shea-online.org/">https://www.shea-online.org/</ext-link>
</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap></sec><sec sec-type="summary" id="cld973-sec-0005"><title>Summary</title><p>SARS&#x02010;CoV&#x02010;2 is a new human pathogen, readily spread via respiratory droplets and the cause of the growing COVID&#x02010;19 pandemic. Men, older adults (&#x0003e;65&#x000a0;years old), and persons with comorbidities are at risk for severe COVID&#x02010;19 and death. Countries have successfully suppressed transmission and mitigated needs for intensive care with robust case/contact detection (testing), isolation of infected/exposed persons, and social distancing. To stop the COVID&#x02010;19 pandemic, the challenge is for all countries to scale up and sustain prevention measures while awaiting the arrival of effective vaccines and therapies.</p></sec></body><back><ref-list content-type="cited-references" id="cld973-bibl-0001"><title>References</title><ref id="cld973-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="cld973-cit-0001">
<string-name>
<surname>Guan</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Ni</surname>
<given-names>WJ</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Clinical characteristics of coronavirus disease 2019 in China</article-title>. <source xml:lang="en">N Engl J Med</source>
<year>2020</year>;<volume>382</volume>:<fpage>1708</fpage>&#x02010;<lpage>1720</lpage>.<pub-id pub-id-type="pmid">32109013</pub-id></mixed-citation></ref><ref id="cld973-bib-0002"><label>2</label><mixed-citation publication-type="miscellaneous" id="cld973-cit-0002">
<collab collab-type="authors">World Health Organization</collab>
. <article-title>Coronavirus disease (COVID&#x02010;19) pandemic</article-title>. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/e">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/e</ext-link>. Accessed April 27, 2020.</mixed-citation></ref><ref id="cld973-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="cld973-cit-0003">
<string-name>
<surname>Lu</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding</article-title>. <source xml:lang="en">Lancet</source>
<year>2020</year>;<volume>395</volume>:<fpage>565</fpage>&#x02010;<lpage>574</lpage>.<pub-id pub-id-type="pmid">32007145</pub-id></mixed-citation></ref><ref id="cld973-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="cld973-cit-0004">
<string-name>
<surname>Kakodkar</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Kaka</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Baig</surname>
<given-names>MN</given-names>
</string-name>. <article-title>A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID&#x02010;19)</article-title>. <source xml:lang="en">Cureus</source>
<year>2020</year>;<volume>6</volume>:<elocation-id>e7560</elocation-id>
<ext-link ext-link-type="uri" xlink:href=".">.</ext-link>
</mixed-citation></ref><ref id="cld973-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="cld973-cit-0005">
<string-name>
<surname>Kristian</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Andersen</surname>
<given-names>KG</given-names>
</string-name>, <string-name>
<surname>Rambaut</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>The proximal origin of SARS&#x02010;CoV&#x02010;2</article-title>. <source xml:lang="en">Nat Med</source>
<year>2020</year>;<volume>26</volume>:<fpage>452</fpage>.</mixed-citation></ref><ref id="cld973-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="cld973-cit-0006">
<string-name>
<surname>Holshue</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>DeBolt</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lindquist</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>First case of 2019 novel coronavirus in the United States</article-title>. <source xml:lang="en">N Engl J Med</source>
<year>2020</year>;<volume>5</volume>:<fpage>929</fpage>&#x02010;<lpage>936</lpage>.</mixed-citation></ref><ref id="cld973-bib-0007"><label>7</label><mixed-citation publication-type="miscellaneous" id="cld973-cit-0007">
<collab collab-type="authors">Centers</collab>
<collab collab-type="authors"> for Disease Control and Prevention</collab>
. <article-title>Coronavirus (COVID&#x02010;19)</article-title>. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/index.html">https://www.cdc.gov/coronavirus/2019-ncov/index.html</ext-link>. Accessed April 27, 2020.</mixed-citation></ref><ref id="cld973-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="cld973-cit-0008">
<string-name>
<surname>van Doremalen</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bushmaker</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>DH</given-names>
</string-name>, et al. <article-title>Aerosol and surface stability of SARS&#x02010;CoV&#x02010;2 as compared with SARS&#x02010;CoV&#x02010;1</article-title>. <source xml:lang="en">N Engl J Med</source>
<year>2020</year>;<volume>382</volume>:<fpage>1564</fpage>&#x02010;<lpage>1567</lpage>.<pub-id pub-id-type="pmid">32182409</pub-id></mixed-citation></ref><ref id="cld973-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="cld973-cit-0009">
<string-name>
<surname>Zhu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ji</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Pang</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Clinical characteristics of 3,062 COVID&#x02010;19 patients: a meta&#x02010;analysis</article-title>. <source xml:lang="en">J Med Virol</source>. Available at: <pub-id pub-id-type="doi">10.1002/jmv.25884</pub-id>
</mixed-citation></ref><ref id="cld973-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="cld973-cit-0010">
<string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Detection of SARS&#x02010;CoV&#x02010;2 in different types of clinical specimens</article-title>. <source xml:lang="en">JAMA</source>
<year>2020</year>;<volume>323</volume>:<fpage>1843</fpage>&#x02010;<lpage>1844</lpage>.</mixed-citation></ref><ref id="cld973-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="cld973-cit-0011">
<string-name>
<surname>Richardson</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hirsch</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Narasimhan</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID&#x02010;19 in the New York City area</article-title>. <source xml:lang="en">JAMA</source>. Available at: <pub-id pub-id-type="doi">10.1001/jama.2020.6775</pub-id>
</mixed-citation></ref><ref id="cld973-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="cld973-cit-0012">
<string-name>
<surname>Hellewell</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Abbott</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gimma</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Feasibility of controlling COVID&#x02010;19 outbreaks by isolation of cases and contacts</article-title>. <source xml:lang="en">Lancet Glob Health</source>
<year>2020</year>;<volume>8</volume>:<fpage>e488</fpage>&#x02010;<lpage>e496</lpage>.<pub-id pub-id-type="pmid">32119825</pub-id></mixed-citation></ref><ref id="cld973-bib-0013"><label>13</label><mixed-citation publication-type="miscellaneous" id="cld973-cit-0013">
<collab collab-type="authors">Institute for Health Metrics and Evaluation</collab>
. <article-title>COVID&#x02010;19 projections</article-title>. Available at: <ext-link ext-link-type="uri" xlink:href="https://covid19.healthdata.org/united-states-of-america">https://covid19.healthdata.org/united-states-of-america</ext-link>. Accessed May 15, 2020.</mixed-citation></ref><ref id="cld973-bib-0014"><label>14</label><mixed-citation publication-type="miscellaneous" id="cld973-cit-0014">
<collab collab-type="authors">USA.gov</collab>
. <article-title>Government response to coronavirus, COVID&#x02010;19</article-title>. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.usa.gov/coronavirus">https://www.usa.gov/coronavirus</ext-link>. Accessed May 15, 2020.</mixed-citation></ref></ref-list></back></article>